Study on the protective effects and mechanisms of atorvastatin in retinal ischemia-reperfusion injury in mice
Experimental Eye Research · 2025
DOI: 10.1016/j.exer.2025.110686 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Eye Research, 2025. Verfasst von Ke Yin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Tianjin Key Laboratory of Retinal Functions and Diseases, Tianjin, 300384, China; Tianjin Branch of National Clinical Research Center for Ocular Dise…. Hauptthemen laut MEDLINE: Reperfusion Injury, Atorvastatin, Retinal Diseases, Hydroxymethylglutaryl-CoA Reductase Inhibitors. Die Arbeit nennt 48 Literaturangaben. Gefördert von: Tianjin Medical University Eye Hospital.
Abstract (Originalsprache)
Retinal ischemia-reperfusion injury (RIRI) is a major cause of visual impairment, with limited effective treatment options. Atorvastatin (Ato), recognized for its pleiotropic effects, has demonstrated potential neuroprotective and vasculoprotective properties. This study aimed to evaluate the protective effects of Ato in a murine RIRI model and elucidate its underlying molecular mechanisms. An RIRI model was established via anterior chamber saline perfusion. Retinal ganglion cell (RGC) survival, superficial vascular density, morphology, and function were assessed, identifying 7 days post-injury as the optimal time point for model evaluation. Subsequent oral Ato administration significantly preserved RGCs, vascular density, and retinal function compared to the untreated RIRI group. Transcriptomic analysis identified insulin-like growth factor 1 (IGF1) as a key differentially expressed gene following Ato treatment. KEGG pathway enrichment analysis suggested IGF1 involvement in the Mitogen-Activated Protein Kinase (MAPK) signaling pathway. qRT-PCR, Western blotting, and immunofluorescence confirmed upregulated IGF1 expression in Ato-treated mice. These findings indicate that Ato may confer neurovascular protection against RIRI by sustaining IGF1/IGF1R expression, potentially engaging downstream MAPK pathways, thereby preserving retinal neurons, vascular integrity, and visual function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Tianjin Key Laboratory of Retinal Functions and Diseases, Tianjin, 300384, China; Tianjin Branch of National Clinical Research Center for Ocular Disease, Tianjin, 300384, China; Eye Institute and School of Optometry, Ti…
Förderung
- Tianjin Medical University Eye Hospital
Zitieren
APA
Yin, K., Li, X., Chen, H., Zhang, Y., Dang, Y., Shi, Y., Dong, L., & Liu, A. (2025). Study on the protective effects and mechanisms of atorvastatin in retinal ischemia-reperfusion injury in mice. Experimental Eye Research. https://doi.org/10.1016/j.exer.2025.110686
Vancouver
Yin K, Li X, Chen H, Zhang Y, Dang Y, Shi Y, et al. Study on the protective effects and mechanisms of atorvastatin in retinal ischemia-reperfusion injury in mice. Experimental Eye Research. 2025. doi:10.1016/j.exer.2025.110686
BibTeX
@article{Yin2025,
author = {Yin, Ke and Li, Xinyi and Chen, Haomin and Zhang, Yanxin and Dang, Yifei and Shi, Yi and Dong, Lijie and Liu, Aihua},
title = {Study on the protective effects and mechanisms of atorvastatin in retinal ischemia-reperfusion injury in mice},
journal = {Experimental Eye Research},
year = {2025},
doi = {10.1016/j.exer.2025.110686}
}
EUVIMED